Metaplanet
3350
Mitsubishi Heavy Industries
7011
Nippon Telegraph & Telephone
9432
4
Kioxia Holdings
285A
5
Honda Motor
7267
JP Stock MarketDetailed Quotes
4572 Carna Biosciences
- 321
- 00.00%
20min DelayMarket to Open Feb 18 15:30 JST
6.13BMarket Cap-4.68P/E (Static)
0High0Low0Volume0Open321Pre Close0.00Turnover51052wk High0.00%Turnover Ratio19.11MShares26052wk Low-78.06EPS TTM4.89BFloat Cap6030Historical HighLossP/E (Static)15.23MShs Float195Historical Low-68.62EPS LYR0.00%Amplitude--Dividend TTM1.91P/B100Lot Size--Div YieldTTM
About Carna Biosciences Company
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
Company Profile
Symbol4572
Company NameCarna Biosciences
Founded2003-04-10
MarketTSE Growth
Employees64
Fiscal Year Ends12-31
AddressBMA 3F 1-5-5 Minatojima-Minamimachi
Zip Code650-0047
Phone078-302-7039
Websitewww.carnabio.com
Company Executives
- Name
- Position
- Salary
- Koichiro Yoshino
- President and Chief Executive Officer
- --
- Teruo Takayanagi
- Director and Chief Development Officer, CarnaBioUSA
- --
- Masaaki Sawa
- Chief Scientific Officer
- --
- Norio Aikawa
- Director of Business Management, Accounting, Human Resources and General Affairs, CarnaBioUSA
- --
- Tokuo Arita
- Independent Director
- --
- Takao Matsui
- Independent Director
- --
- Kaori Suzuki
- Independent Director
- --
- Tsuguo Ogasawara
- Independent Director
- --